United Kingdom · Question · Written question
UIN 107901
Lipoedema: Medical Treatments
Introduced
22 January 2026
Last action
27 January 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
27 January 2026
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential role of GLP-1 medications in reducing inflammation and pain associated with lipoedema.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
22 January 2026
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential role of GLP-1 medications in reducing inflammation and pain associated with lipoedema.
Source: Commons
27 January 2026
Answer
The Department has not made any assessment of the potential role of GLP-1 medications in reducing inflammation and pain associated with lipoedema. Newly licensed medicines are appraised by the National Institute for Health and Care Excellence (NICE), whic...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-01-22/107901
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1874347
- uk · wq-1874347 · source updated 27 January 2026